ARTICLE | Company News
Pluristem Life Systems Inc., Stem Cell Innovations deal
February 26, 2007 8:00 AM UTC
SCLL received rights to market PLRS's PLX-1 and 3-D PluriX bioreactor in Asia, excluding Japan. PLX-1 is an adjuvant cell therapy based on placenta-expanded mesenchymal cells. PLX-1 is currently in pr...